Nephrogenic diabetes insipidus associated with foscarnet treatment of cytomegalovirus retinitis.
Farese
R V
RV
San Francisco General Hospital, California.
Schambelan
M
M
Hollander
H
H
Stringari
S
S
Jacobson
M A
MA
D000163:Acquired Immunodeficiency Syndrome / Q000150:complications; D000328:Adult; D000998:Antiviral Agents / Q000009:adverse effects* / Q000627:therapeutic use; D003586:Cytomegalovirus Infections / Q000188:drug therapy*; D003919:Diabetes Insipidus / Q000139:chemically induced*; D015828:Eye Infections, Viral / Q000188:drug therapy*; D017245:Foscarnet; D006801:Humans; D007674:Kidney Diseases / Q000139:chemically induced; D008297:Male; D010746:Phosphonoacetic Acid / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use; D012173:Retinitis / Q000188:drug therapy* / Q000209:etiology
D000998:Antiviral Agents; D017245:Foscarnet; D010746:Phosphonoacetic Acid